Revealing the pathogenesis of autoimmune hepatitis and research progress in drug discovery from hepatic immune cells and intercellular communication signaling mechanisms
Open Access
- 18 June 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1871133
Abstract
Autoimmune hepatitis (AIH) is an immune-mediated chronic liver disease with an increasing incidence. The complex pathogenesis of AIH poses significant challenges for clinical treatment. In recent years, with the introduction of cutting-edge concepts such as “immune–metabolic interplay” and “intercellular communication networks,” along with novel detection methods and technologies, research on the pathogenesis of AIH has shifted from a single-molecular-mechanism perspective to a systematic regulatory network analysis. This shift has not only provided more research evidence for a deeper understanding of the molecular biological mechanisms underlying AIH but also offers a potential reference for the development of targeted therapeutic drugs for AIH based on novel targets. Therefore, this review starts with aberrant activation signals from key immune cells—including dendritic cells (DCs), macrophages (Mφ), and T/B cells—and integrates the intercellular signaling communication mechanisms between hepatocytes, cholangiocytes, and immune cells to systematically summarize the key molecular biological mechanisms and targets identified in recent years, providing a reference for future elucidation of the critical mechanisms of AIH. On this basis, the review further integrates the current application and research progress of clinically used AIH therapeutic drugs, as well as those at various stages of development, including potential therapeutic compounds. It discusses the limitations of current clinical drugs and evaluates the feasibility and future application potential of potential compounds for AIH treatment in preclinical and clinical studies, thereby offering comprehensive research evidence for the management of AIH.Keywords
This publication has 173 references indexed in Scilit:
- PD‐1 + CD8 + T Cell‐Mediated Hepatocyte Pyroptosis Promotes Progression of Murine Autoimmune Liver DiseaseAdvanced Science, 2024
- Astaxanthin Alleviates Autoimmune Hepatitis by Modulating CD8+ T Cells: Insights From Mass Cytometry and Single‐Cell RNA Sequencing AnalysesAdvanced Science, 2024
- We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver DiseasesHepatology, 2021
- The Clinical Significance of Hepatic CD69+CD103+CD8+ Resident‐Memory T Cells in Autoimmune HepatitisHepatology, 2021
- CD4+ T Cell‐Released Extracellular Vesicles Potentiate the Efficacy of the HBsAg Vaccine by Enhancing B Cell ResponsesAdvanced Science, 2019
- The Impact of Autoimmune Hepatitis and Its Treatment on Health UtilityHepatology, 2018
- Regulatory T‐cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitisHepatology, 2017
- A Multifaceted Imbalance of T Cells with Regulatory Function Characterizes Type 1 Autoimmune Hepatitis†,‡Hepatology, 2010
- Forkhead Box P3+ Regulatory T Cell Underlies Male Resistance to Experimental Type 2 Autoimmune HepatitisHepatology, 2010
- Abnormal CTLA‐4 function in T cells from patients with systemic lupus erythematosusEuropean Journal of Immunology, 2010